Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.
暂无分享,去创建一个
R. Gie | H. Kirchner | A. Mandalakas | G. Walzl | H. Grewal | M. Cotton | A. Hesseling | H. S. Schaaf | H. L. Kirchner | H. Schaaf
[1] I. Kitai,et al. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic. , 2015, Journal of the Pediatric Infectious Diseases Society.
[2] P. Kouw,et al. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. , 2014, American journal of respiratory and critical care medicine.
[3] T. M. Doherty,et al. Influence of Age and Nutritional Status on the Performance of the Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube in Young Children Evaluated for Tuberculosis in Southern India , 2014, The Pediatric infectious disease journal.
[4] S. Hammer,et al. Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure , 2014, PloS one.
[5] P. Dodd,et al. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. , 2014, The Lancet. Global health.
[6] E. Hershfield,et al. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection , 2013, Pediatric Clinical Practice Guidelines & Policies.
[7] A. Smith,et al. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis , 2014, BMC Infectious Diseases.
[8] R. Gie,et al. Detecting Tuberculosis Infection in HIV-infected Children: A Study of Diagnostic Accuracy, Confounding and Interaction , 2012, The Pediatric infectious disease journal.
[9] N. Papadopoulos,et al. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. , 2012, The Journal of pediatrics.
[10] C. Dye,et al. Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries , 2012, Emerging infectious diseases.
[11] R. Basu Roy,et al. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. , 2012, American journal of respiratory and critical care medicine.
[12] R. Gie,et al. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting , 2012, Thorax.
[13] P. White,et al. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis , 2012, Thorax.
[14] R. Gie,et al. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] C. Sismanidis,et al. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. , 2012, The Journal of infectious diseases.
[16] J. Bellanti,et al. Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs) , 2012, Allergy and asthma proceedings.
[17] C. Wiysonge,et al. The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis , 2011, The Pediatric infectious disease journal.
[18] A. Benedetti,et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] K. C. Smith,et al. Comparing the Tuberculin Skin Test and T-SPOT.TB Blood Test in Children , 2011, Pediatrics.
[20] I. Adetifa,et al. Treatment of latent tuberculosis infection in HIV infected persons. , 2010, The Cochrane database of systematic reviews.
[21] H. Kirchner,et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis , 2008, Thorax.
[22] F. Cobelens,et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. , 2007, American journal of respiratory and critical care medicine.
[23] R. Gie,et al. A Refined Symptom-Based Approach to Diagnose Pulmonary Tuberculosis in Children , 2006, Pediatrics.
[24] T. Scriba,et al. Impaired IFN-γ-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART , 2006, AIDS.
[25] S. Lawn,et al. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort , 2005, AIDS.
[26] J. Deeks,et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study , 2005, The Lancet.
[27] R. Gie,et al. A proposed radiological classification of childhood intra-thoracic tuberculosis , 2004, Pediatric Radiology.
[28] R. Gie,et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[29] J. Deeks,et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.
[30] C. Gatsonis,et al. Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative , 2003, Clinical chemistry and laboratory medicine.
[31] D. Rennie,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.
[32] C. Hung,et al. Restoration of Cellular Immunity Against Tuberculosis in Patients Coinfected With HIV‐1 and Tuberculosis With Effective Antiretroviral Therapy: Assessment by Determination of CD69 Expression on T Cells After Tuberculin Stimulation , 2000, Journal of acquired immune deficiency syndromes.
[33] P. Andersen,et al. Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.
[34] D. Cook,et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. , 1999, The Cochrane database of systematic reviews.
[35] B. Everitt,et al. Analysis of longitudinal data , 1998, British Journal of Psychiatry.
[36] P. Albert,et al. Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.
[37] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[38] K. H. Hsu,et al. Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children. , 1974, JAMA.
[39] R. Lodha,et al. Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis , 2014, European Journal of Clinical Nutrition.
[40] Sandy F. Price,et al. Trends in tuberculosis - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.
[41] Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle- income countries , 2011 .
[42] K. Castro,et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[43] Robert H. Pratt,et al. Trends in tuberculosis--United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.
[44] A. Dhar,et al. National Institute for Health and Clinical Excellence , 2005 .
[45] J. Volmink,et al. Treatment of latent tuberculosis infection in HIV infected persons. , 2004, The Cochrane database of systematic reviews.